Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer

Introduction: The GenesWell Breast Cancer Test (BCT) is a recently developed multigene assay that predicts the risk of distant recurrence in patients with early breast cancer. Here, we analyzed the concordance of the BCT score with the Oncotype DX recurrence score (RS) for risk stratification in Asi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Mi Jeong, Lee, Jeong Eon, Jeong, Joon, Woo, Sang Uk, Han, Jinil, Kang, Byeong-il, Kim, Jee-Eun, Moon, Youngho, Lee, Sae Byul, Lee, Seonghoon, Choi, Yoon-La, Kwon, Youngmi, Song, Kyoung, Gong, Gyungyub, Shin, Young Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670782/
https://www.ncbi.nlm.nih.gov/pubmed/31404265
http://dx.doi.org/10.3389/fonc.2019.00667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670782/
https://www.ncbi.nlm.nih.gov/pubmed/31404265
http://dx.doi.org/10.3389/fonc.2019.00667

Ejemplares similares